Evidence map›Paper›PMID 41577997›Full record

ArticleCommunications medicine2026

Hybrid deep learning framework MedFusionNet assists multilabel biomedical risk stratification from imaging and tabular data.

Sergey Gorbachev, Abhishek Dixit, Ashish Mani, Zhijian Wang

Abstract read
In one paragraph

Article in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sergey GorbachevSchool of Mathematics and Big Data, Chongqing University of Education, Chongqing, China. gorbachev@cque.edu.cn.ORCID http://orcid.org/0000-0001-8096-1327
Abhishek DixitSchool of Mathematics and Big Data, Chongqing University of Education, Chongqing, China. abhishekd@cque.edu.cn.ORCID http://orcid.org/0000-0001-9920-2478
Ashish ManiSchool of Mathematics and Big Data, Chongqing University of Education, Chongqing, China.
Zhijian WangYuyao Robotics Research Center, Zhejiang University Robotics Institute, Ningbo, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMulti-label medical image classification is challenging due to complex inter-label dependencies, data imbalance, and the need to integrate multiple data modalities. These challenges hinder the development of robust and interpretable diagnostic systems capable of leveraging diverse clinical information.

methodWe propose a cancer risk stratification framework that combines univariate thresholding with multivariate modeling using a hybrid parallel deep learning architecture, MedFusionNet. First, univariate thresholds are applied to identify the top-N discriminative features for each label. These selected features are then incorporated into MedFusionNet, which integrates Self-Attention Mechanisms, Dense Connections, and Feature Pyramid Networks (FPNs). The architecture is further extended for multi-modal learning by fusing image data with corresponding textual and clinical metadata. Self-Attention captures dependencies across image regions, labels, and modalities; Dense Connections enable efficient feature propagation; and FPNs support multi-scale representation and cross-modal fusion.

resultsExtensive evaluations on multiple datasets, including NIH ChestX-ray14 and a custom cervical cancer dataset, confirm that MedFusionNet consistently outperforms existing models. The framework delivers higher accuracy, improved robustness, and enhanced interpretability compared to traditional deep learning approaches.

conclusionsMedFusionNet provides an effective and scalable solution for multi-label medical image classification and cancer risk stratification. By integrating multi-modal information and advanced architectural components, it improves predictive performance while maintaining high interpretability, making it well-suited for real-world clinical applications.

Identifiers

PMID41577997
PMCPMC12830585

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.